Ayr Wellness Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Steven Cohen

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	less than a year
Proprietà del CEO	n/a
Durata media del management	2yrs
Durata media del Consiglio di amministrazione	3.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Steven Cohen (61 yo)

less than a year

Mandato

Mr. Steven Michael Cohen, J.D., is Interim Chief Executive Officer of Ayr Wellness Inc. from September 18, 2024 and previously served as outside legal advisor to the Company. He serves as Independent Direc...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Brad Asher	Chief Financial Officer	5yrs	US$1.03m	0.28% € 215.1k
James Mendola	Interim Co-Chief Revenue Officer	5.5yrs	US$913.76k	0.52% € 398.5k
Paul Fisher	Chief Transformation Officer	no data	US$599.99k	0.051% € 38.5k
Steven Cohen	Interim Chief Executive Officer	less than a year	Nessun dato	Nessun dato
George DeNardo	Chief Operating Officer	less than a year	Nessun dato	Nessun dato
Sarvesh Mathur	Chief Technology Officer	no data	Nessun dato	Nessun dato
Anya Varga	Chief People Officer	3yrs	Nessun dato	0.0076% € 5.8k
Mark Bruno	Senior Vice President of Cultivation	no data	Nessun dato	Nessun dato
Khari Edwards	Head of CSR	no data	Nessun dato	Nessun dato
Julie Winter	Interim Co-Chief Revenue Officer	less than a year	Nessun dato	Nessun dato

2.0yrs

Durata media

Gestione esperta: Il team dirigenziale di 3KJB è considerato esperto (durata media dell'incarico 2 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Joyce Johnson-Miller	Independent Director	2.8yrs	US$150.00k	0.0030% € 2.3k
Louis Karger	Chairman of the Board	5.5yrs	US$50.00k	0.018% € 13.7k
Charles Miles	Independent Director	7.2yrs	US$285.00k	0.21% € 158.7k
Glenn Isaacson	Independent Director	4.3yrs	US$125.00k	0.13% € 102.3k
Michael Warren	Independent Director	1.3yrs	US$89.56k	Nessun dato
Jared Cohen	Independent Director	less than a year	Nessun dato	Nessun dato

3.5yrs

Durata media

57yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 3KJB sono considerati esperti (durata media dell'incarico 3.5 anni).

Ayr Wellness Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

AYR Wellness Inc. Announces Chief Executive Officer Changes

AYR Wellness Inc. Announces Executive Changes

Less than half of directors are independent

Ayr Wellness Inc., Annual General Meeting, May 17, 2024

AYR Wellness Inc. Announces Jared Cohen to Join the Board of Directors

Ayr Wellness Inc. Appoints Michael Warren to Board of Directors

Recent updates

AYR Wellness Inc. Launches Later Days Fruit-Flavored Vape Collection

New major risk - Shareholder dilution

Third quarter 2024 earnings released: US$0.44 loss per share (vs US$0.24 loss in 3Q 2023)

Ayr Wellness Inc. Provides Earnings Guidance for the Fourth Quarter 2024

New minor risk - Market cap size

Ayr Wellness Inc. to Report Q3, 2024 Results on Nov 13, 2024

New major risk - Shareholder dilution

AYR Wellness Inc. Announces Chief Executive Officer Changes

New major risk - Shareholder dilution

Second quarter 2024 earnings released: US$0.34 loss per share (vs US$0.42 loss in 2Q 2023)

Ayr Wellness Inc. Provides Revenue Guidance for the Third Quarter of 2024

AYR Wellness Inc. Announces Executive Changes

Ayr Wellness Inc. to Report Q2, 2024 Results on Aug 02, 2024

First quarter 2024 earnings released: US$1.08 loss per share (vs US$0.13 loss in 1Q 2023)

Ayr Wellness Inc. Provides Earnings Guidance for the Second Quarter of 2024

Ayr Wellness Inc. to Report Q1, 2024 Results on May 15, 2024

Forecast to breakeven in 2025

Ayr Wellness Inc. Launches Kynd Premium Edibles in Florida and Nevada

Less than half of directors are independent

Ayr Wellness Inc., Annual General Meeting, May 17, 2024

Full year 2023 earnings released: US$1.16 loss per share (vs US$3.58 loss in FY 2022)

Ayr Wellness Inc. Provides Earnings Guidance for the First Quarter of 2024

Ayr Wellness Inc. announced that it expects to receive $48.857663 million in funding

New major risk - Shareholder dilution

Ayr Wellness Inc. to Report Q4, 2023 Results on Mar 13, 2024

AYR Wellness Inc. Announces Jared Cohen to Join the Board of Directors

Third quarter 2023 earnings released: US$0.24 loss per share (vs US$0.52 loss in 3Q 2022)

Ayr Wellness Inc. Provides Earnings Guidance for the Fourth Quarter of 2023

Ayr Wellness Inc. to Report Q3, 2023 Results on Nov 16, 2023

New minor risk - Market cap size

Now 28% undervalued

Second quarter 2023 earnings released

Ayr Wellness Inc. Provides Earnings Guidance for the Second Half of 2023 and for the Year 2024

Ayr Wellness Inc. Appoints Michael Warren to Board of Directors

Now 21% undervalued after recent price drop

Forecast to breakeven in 2025

First quarter 2023 earnings released: US$0.13 loss per share (vs US$0.11 loss in 1Q 2022)

Full year 2022 earnings released: US$3.58 loss per share (vs US$0.30 loss in FY 2021)

Ayr Wellness Inc. Announces Chief Executive Officer Changes

AZ Goat, LLC entered into a definitive agreement to acquire Blue Camo, LLC from Ayr Wellness Inc. (CNSX:AYR.A) for $20 million.

Forecast to breakeven in 2024

Ayr Wellness Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Ayr Wellness Inc. Appoints David Goubert as President, Effective from November 1, 2022

Ayr Wellness Inc. Brings Concentrates Brand Haze to Florida

Ayr Wellness Inc. to Report Q3, 2022 Results on Nov 10, 2022

Ayr Wellness Inc. Announces the Launch of Lost in Translation Across Four Additional States

Independent Director recently bought €60k worth of stock

Second quarter 2022 earnings released: US$0.56 loss per share (vs US$0.36 loss in 2Q 2021)

Ayr Wellness Inc. Provides Earnings Guidance for the Third Quarter and Fourth Quarter of Fiscal Year 2022

Ayr Wellness Receives Key Massachusetts Regulatory Approval for Adult-Use Sales in Somerville, Subject to Municipal Approval

Ayr Wellness Inc. Receives Key Massachusetts Regulatory Approval for Adult-Use Sales in Somerville, Subject to Municipal Approval; Ayr Announces Approval for Phase 1 of Milford Cultivation Expansion

Ayr Wellness Inc. to Report Q2, 2022 Results on Aug 18, 2022

Independent Director recently bought €92k worth of stock

Ayr Wellness Inc. to Begin Adult-Use Sales in Its Three New Jersey Dispensaries

Ayr Wellness Inc Receives Final License to Sell Adult-Use Cannabis in Watertown

Forecast breakeven date pushed back to 2024

Ayr Wellness Inc Receives Final License to Sell Adult-Use Cannabis in Watertown

Ayr Wellness Inc. Receives Approval to Begin New Jersey Adult-Use Retail Sales

First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.38 loss in 1Q 2021)

Ayr Wellness Inc. (CNSX:AYR.A) completed the acquisition of Herbal Remedies Dispensaries, LLC.

Ayr Wellness Receives Approval from New Jersey Cannabis Regulatory Commission to Begin New Jersey Adult-Use Retail Sales

Ayr Wellness Inc Receives Final License to Sell Adult-Use Cannabis in the Heart of Boston’s Back Bay, the Company’s First Adult-Use Dispensary in Greater Boston

Ayr Wellness Inc. to Report Q1, 2022 Results on May 26, 2022

Ayr Wellness Inc., Annual General Meeting, Jun 23, 2022

Ayr Wellness Inc. Announces Brand Launches in Massachusetts and Ohio

Ayr Wellness Inc. Announces the Launch of Kynd Premium Flower in Florida

Ayr Wellness Announces New Launches for Secret Orchard, Levia, Stix Preroll Co., and Origyn Extracts

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Ayr Wellness Inc. (CNSX:AYR.A) completed the acquisition of Cultivauna, LLC.